News from immunocore limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

09 Nov, 2016, 15:40 GMT Immunocore Presents Positive Monotherapy Data in Uveal Melanoma at the Society for Melanoma Research (SMR) 2016 Congress

- IMCgp100 Demonstrates Clear Early Evidence of Monotherapy Activity in Patients With Uveal Melanoma - Pivotal Phase II Clinical Study on Track to be ...


06 Jun, 2016, 08:57 BST Immunocore Presents Positive IMCgp100 Phase I Data at the 2016 ASCO Annual Meeting

- Full Data Presented From The First-In-Human Study of Imcgp100 in Metastatic Melanoma, Treating 84 Patients - Prolonged Responses Were Observed in...


30 Mar, 2016, 07:00 BST Immunocore's IMCgp100 Starts Phase I Trial for the Treatment of Uveal Melanoma

Immunocore, a world-leading biotechnology company developing novel T cell receptor (TCR) based biological drugs to treat cancer, infectious diseases...


20 Jan, 2016, 07:00 GMT Immunocore Starts Clinical Trial with IMCgp100 in Combination with MedImmune Immunotherapies Durvalumab and Tremelimumab

Immunocore Limited, a world-leading biotechnology company developing novel T cell receptor (TCR) based biological drugs to treat cancer, viral...


06 Jan, 2016, 07:00 GMT Immunocore and GlaxoSmithKline Select First ImmTAC Clinical Candidate in Discovery Collaboration

Immunocore Limited, a world-leading biotechnology company developing novel T cell receptor (TCR) based biological drugs to treat cancer, viral...


03 Dec, 2015, 07:00 GMT Immunocore Wins Biotech of the Year at the SCRIP Awards 2015

Immunocore Limited, a world-leading biotechnology company developing novel T cell receptor (TCR) based biological drugs to treat cancer, viral...


09 Sep, 2015, 07:00 BST Immunocore's IMCgp100 Accepted for Adaptive Pathway Pilot Programme

Potential for Accelerated Regulatory Approval in Europe Immunocore Limited, a world-leading biotechnology company developing novel T cell receptor...


16 Jul, 2015, 07:00 BST Immunocore Secures $320 Million (£205 Million) in Europe's Largest Private Life Sciences Financing

- Funding to advance proprietary pipeline to build a premier biotech company Immunocore Limited, a world-leading biotechnology company developing...


12 Jun, 2015, 10:08 BST Immunocore Wins Emerging Star of the Year Award at the European Mediscience Awards 2015

Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer, viral infections and autoimmune disease, ...


11 May, 2015, 07:00 BST Immunocore to Attend Citi European Healthcare Conference 2015 and BioTrinity 2015

Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer, viral infections and autoimmune...


20 Apr, 2015, 07:00 BST Immunocore Announces Positive Clinical Trial Data for Novel First-in-Class Immunotherapy at AACR Annual Meeting 2015

IMCgp100 shows partial and complete durable responses in Phase I/IIa trial in patients with advanced melanoma Immunocore Limited, a world-leading...


16 Apr, 2015, 07:00 BST Immunocore and MedImmune Announce New Collaboration to Conduct Immuno-oncology Combination Trails in Melanoma

Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer and other diseases, and MedImmune, the...


08 Apr, 2015, 07:00 BST Immunocore to Present IMCgp100 Clinical Trial Data at AACR Annual Meeting 2015

~ A Phase I/IIa study of IMCgp100: partial and complete durable responses with a novel first-in-class immunotherapy for advanced melanoma ~...


01 Apr, 2015, 07:00 BST Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer

Immunocore Limited ("the Company"), a world-leading biotechnology company developing novel biological drugs to treat cancer, viral infections and...


30 Mar, 2015, 07:00 BST Immunocore Appoints Professor Sir John Bell to its Board of Directors

Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer, viral infections and autoimmune disease, ...